Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib in New Onset Type 1 Diabetes
NCT04774224Phase 2Completed
- Sponsor
- St Vincent's Institute of Medical Research
- Start
- Oct 2020
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib in type 1 diabetes mellitus (T1D), sponsored by St Vincent's Institute of Medical Research. Started Oct 2020; status: completed.
02
Drugs
baricitinib
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04774224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04774224.